Altimmune, Inc.
ALT
$3.33
-$0.04-1.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.83M | -22.56M | -27.36M | -19.01M | -22.15M |
| Total Depreciation and Amortization | 23.00K | 23.00K | 26.00K | 27.00K | 30.00K |
| Total Amortization of Deferred Charges | 455.00K | -- | -171.00K | 113.00K | 58.00K |
| Total Other Non-Cash Items | 2.39M | 3.59M | 4.44M | 3.44M | 3.18M |
| Change in Net Operating Assets | -4.27M | -1.99M | 3.62M | 3.53M | -472.00K |
| Cash from Operations | -24.22M | -20.94M | -19.45M | -11.90M | -19.35M |
| Capital Expenditure | -32.00K | -21.00K | -1.00K | 0.00 | -10.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -221.41M | -3.67M | -79.16M | -149.32M | 101.12M |
| Cash from Investing | -221.44M | -3.69M | -79.16M | -149.32M | 101.11M |
| Total Debt Issued | -- | -- | 20.00M | 0.00 | 14.60M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 211.49M | 79.26M | 61.65M | 39.67M | 38.03M |
| Repurchase of Common Stock | -- | -695.00K | -25.00K | 0.00 | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -420.00K | -89.00K | -490.00K | -322.00K | -385.00K |
| Cash from Financing | 211.07M | 78.47M | 81.13M | 39.35M | 52.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.59M | 53.84M | -17.48M | -121.87M | 134.00M |